STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMVT
  4. [ARS] Immunovant, Inc. SEC Filing

[ARS] Immunovant, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Immunovant, Inc.

ARS Filing - Immunovant, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Immunovant, Inc. (IMVT)

Acceptance Date: 2025-07-09T16:57:33.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Immunovant Inc

NASDAQ:IMVT

View IMVT Stock Overview →

IMVT Rankings

#1378 Ranked by Market Cap
N/A Ranked by Dividends

IMVT Latest News

Feb 6, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
Jan 23, 2026
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
Dec 11, 2025
Immunovant Announces Pricing of $550 Million Common Stock Financing
Nov 10, 2025
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
Oct 27, 2025
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

IMVT Latest SEC Filings

Mar 20, 2026
[Form 4] Immunovant, Inc. Insider Trading Activity
Feb 27, 2026
[Form 4] Immunovant, Inc. Insider Trading Activity
Feb 10, 2026
[144] Immunovant, Inc. SEC Filing
Feb 6, 2026
[10-Q] Immunovant, Inc. Quarterly Earnings Report
Feb 6, 2026
[8-K] Immunovant, Inc. Reports Material Event

IMVT Stock Data

5.16B
85.12M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
DURHAM